Literature DB >> 1242211

Congenital muscular dystrophy: a clinico-pathological and follow-up study of 15 patients.

M Donner, J Rapola, H Somer.   

Abstract

Fifteen patients with a presumptive diagnosis of congenital muscular dystrophy were followed for up to 15 years. The diagnosis was based on clinical, enzyme, histological and neurophysiological examinations. The group formed nine per cent of the 160 children suffering from neuromuscular disorders seen at the same hospital during a period of ten years. The muscle weakness was generalized and also involved respiratory muscles and the face. 60 per cent of the children had congenital contractures; these were well amenable to treatment. However, there was a strong tendency for new contractures to form from the second to third year onwards. There were also other signs indicating that the disease process was changing with time. The deep tendon reflexes were present in the beginning but later were usually lost. The serum creatine kinase was raised even to high levels in the first one to two years and gradually sank to normal or near normal values. The histopathological findings changed with time from relatively slight changes compatible with a muscle destroying process to inactive type lesions characterized by fibrotic and particularly adipose tissue replacing muscle fibres. On the basis of these findings it can be assumed that the active disease process is at its height during intrauterine and early postnatal life and then wanes leaving an outburnt or cicatrical state in which new contractures easily develop causing possible deterioration with time. Active treatment is thus of great importance both to overcome neonatal contractures and to prevent new ones to develop.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1242211     DOI: 10.1055/s-0028-1091666

Source DB:  PubMed          Journal:  Neuropadiatrie        ISSN: 0028-3797


  8 in total

1.  Occidental type cerebromuscular dystrophy: a report of eleven cases.

Authors:  H Topaloğlu; K Yalaz; Y Renda; M Cağlar; S Göğüs; G Kale; K Gücüyener; G Nurlu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Neuropathological findings in muscle-eye-brain disease (MEB-D). Neuropathological delineation of MEB-D from congenital muscular dystrophy of the Fukuyama type.

Authors:  Q H Leyten; K Renkawek; W O Renier; F J Gabreëls; C M Mooy; H J ter Laak; R A Mullaart
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Authors:  Q H Leyten; H J ter Laak; F J Gabreëls; W O Renier; K Renkawek; R C Sengers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Congenital muscular dystrophy and cerebellar vermis agenesis in two brothers.

Authors:  O Arancio; L G Bongiovanni; G Bonadonna; G Tomelleri; D De Grandis
Journal:  Ital J Neurol Sci       Date:  1988-10

5.  Congenital muscular dystrophy and severe central nervous system atrophy in two siblings.

Authors:  Q H Leyten; P G Barth; F J Gabreëls; K Renkawek; W O Renier; A A Gabreëls-Festen; H J ter Laak; M G Smits
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Autosomal recessive sudden unexpected death in children probably caused by a cardiomyopathy associated with myopathy.

Authors:  K Fried; S Beer; E Vure; M Algom; Y Shapira
Journal:  J Med Genet       Date:  1979-10       Impact factor: 6.318

Review 7.  Ullrich's congenital atonic sclerotic muscular dystrophy. A case report.

Authors:  L De Paillette; J Aicardi; F Goutières
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

8.  Congenital muscular dystrophy: brain alterations in an unselected series of Western patients.

Authors:  C P Trevisan; C Carollo; P Segalla; C Angelini; P Drigo; R Giordano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.